|
|
||||||||
MINIREVIEWS
1Department of Endocrinology, Heinrich-Heine-University, D-40225 Düsseldorf; and 2Aventis Pharma, DG Metabolic Diseases, D-65926 Frankfurt, Germany
The regulation of hepatic gluconeogenesis is an important process in the adjustment of the blood glucose level, and pathological changes in the glucose production of the liver are a central characteristic in type 2 diabetes. The pharmacological intervention in signaling events that regulate the expression of the key gluconeogenic enzymes phosphoenolpyruvate carboxykinase (PEPCK) and the catalytic subunit glucose-6-phosphatase (G-6-Pase) is regarded as a potential strategy for the treatment of metabolic aberrations associated with this disease. However, such intervention requires a detailed understanding of the molecular mechanisms involved in the regulation of this process. Glucagon and glucocorticoids are known to increase hepatic gluconeogenesis by inducing the expression of PEPCK and G-6-Pase. The coactivator protein PGC-1 has been identified as an important mediator of this regulation. In contrast, insulin is known to suppress both PEPCK and G-6-Pase gene expression by the activation of PI 3-kinase. However, PI 3-kinase-independent pathways can also lead to the inhibition of gluconeogenic enzymes. This review focuses on signaling mechanisms and nuclear events that transduce the regulation of gluconeogenic enzymes.
insulin; liver; transcriptional regulation; glucose-6-phosphatase; phosphoenolpyruvate carboxykinase
This article has been cited by other articles:
![]() |
E. S. Buhl, S. Neschen, S. Yonemitsu, J. Rossbacher, D. Zhang, K. Morino, A. Flyvbjerg, P. Perret, V. Samuel, J. Kim, et al. Increased hypothalamic-pituitary-adrenal axis activity and hepatic insulin resistance in low-birth-weight rats Am J Physiol Endocrinol Metab, November 1, 2007; 293(5): E1451 - E1458. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. J. Bradford and M. S. Allen Depression in Feed Intake by a Highly Fermentable Diet Is Related to Plasma Insulin Concentration and Insulin Response to Glucose Infusion J Dairy Sci, August 1, 2007; 90(8): 3838 - 3845. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Azzout-Marniche, C. Gaudichon, C. Blouet, C. Bos, V. Mathe, J.-F. Huneau, and D. Tome Liver glyconeogenesis: a pathway to cope with postprandial amino acid excess in high-protein fed rats? Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2007; 292(4): R1400 - R1407. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Loor, H. M. Dann, N. A. J. Guretzky, R. E. Everts, R. Oliveira, C. A. Green, N. B. Litherland, S. L. Rodriguez-Zas, H. A. Lewin, and J. K. Drackley Plane of nutrition prepartum alters hepatic gene expression and function in dairy cows as assessed by longitudinal transcript and metabolic profiling Physiol Genomics, January 12, 2007; 27(1): 29 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
M J Walsh, J R Jonsson, M M Richardson, G M Lipka, D M Purdie, A D Clouston, and E E Powell Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1 Gut, April 1, 2006; 55(4): 529 - 535. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. M. W. van Kempen, S. N. van der Crabben, M. T. Ackermans, E. Endert, J. H. Kok, and H. P. Sauerwein Stimulation of gluconeogenesis by intravenous lipids in preterm infants: response depends on fatty acid profile Am J Physiol Endocrinol Metab, April 1, 2006; 290(4): E723 - E730. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Asensio, M. Jimenez, F. Kuhne, F. Rohner-Jeanrenaud, and P. Muzzin The Lack of {beta}-Adrenoceptors Results in Enhanced Insulin Sensitivity in Mice Exhibiting Increased Adiposity and Glucose Intolerance Diabetes, December 1, 2005; 54(12): 3490 - 3495. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Fukui, T. Wada, S. Kagawa, K. Nagira, M. Ikubo, H. Ishihara, M. Kobayashi, and T. Sasaoka Impact of the Liver-Specific Expression of SHIP2 (SH2-Containing Inositol 5'-Phosphatase 2) on Insulin Signaling and Glucose Metabolism in Mice Diabetes, July 1, 2005; 54(7): 1958 - 1967. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. M. Watts, V. P. Manchem, T. A. Leedom, A. L. Rivard, R. A. McKay, D. Bao, T. Neroladakis, B. P. Monia, D. M. Bodenmiller, J. X.-C. Cao, et al. Reduction of Hepatic and Adipose Tissue Glucocorticoid Receptor Expression With Antisense Oligonucleotides Improves Hyperglycemia and Hyperlipidemia in Diabetic Rodents Without Causing Systemic Glucocorticoid Antagonism Diabetes, June 1, 2005; 54(6): 1846 - 1853. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. M. Krudys, M. G. Dodds, S. M. Nissen, and P. Vicini Integrated model of hepatic and peripheral glucose regulation for estimation of endogenous glucose production during the hot IVGTT Am J Physiol Endocrinol Metab, May 1, 2005; 288(5): E1038 - E1046. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Xu, S. Ji, D. Y Venable, J. L Franklin, and J. L Messina Prolonged insulin treatment inhibits GH signaling via STAT3 and STAT1 J. Endocrinol., March 1, 2005; 184(3): 481 - 492. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Vuguin, E. Raab, B. Liu, N. Barzilai, and R. Simmons Hepatic Insulin Resistance Precedes the Development of Diabetes in a Model of Intrauterine Growth Retardation Diabetes, October 1, 2004; 53(10): 2617 - 2622. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Rangwala, A. S. Rich, B. Rhoades, J. S. Shapiro, S. Obici, L. Rossetti, and M. A. Lazar Abnormal Glucose Homeostasis due to Chronic Hyperresistinemia Diabetes, August 1, 2004; 53(8): 1937 - 1941. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. R. Banerjee, S. M. Rangwala, J. S. Shapiro, A. S. Rich, B. Rhoades, Y. Qi, J. Wang, M. W. Rajala, A. Pocai, P. E. Scherer, et al. Regulation of Fasted Blood Glucose by Resistin Science, February 20, 2004; 303(5661): 1195 - 1198. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |